Navigation Links
Align Technology to Announce Fourth Quarter and 2007 Year End Financial Results on January 29, 2008
Date:1/4/2008

SANTA CLARA, Calif., Jan. 4 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign(R), a proprietary method of straightening teeth without wires and brackets, announced today that the Company will report fourth quarter and 2007 year end financial results on Tuesday, January 29, 2008, after the close of market. Financial results will be released over PR Newswire and First Call and will be available on the Investor Relations section of the Company's website at http://investor.aligntech.com.

Following the press release, Align Technology executives will host a conference call to review fourth quarter and 2007 year end financial results. The conference call will begin at 4:30 p.m. ET (1:30 p.m. PT) and will also be available as an audio web cast live via the Internet. To access the web cast, please visit the Investor Relations section of Align Technology's website at http://investor.aligntech.com. To access the conference call, please dial 201-689-8341 approximately fifteen minutes prior to the start of the call.

If you are unable to listen to the call, an archived web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with account number 292 followed by # and conference number 268148 followed by #. The replay must be accessed from international locations by dialing 201-612-7415 and using the same account and conference numbers referenced above. The telephonic replay will be available through 5:30 p.m. ET on February 12, 2008.

Align Technology Executive to Present At JPMorgan Healthcare Conference (corrected time)

In addition, Thomas M. Prescott, president and chief executive officer of Align Technology, is scheduled to speak at the 26th Annual JPMorgan Healthcare Conference. Both the presentation and breakout session, as noted below, will be web cast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the web site for approximately three months. Details follow:

Conference: JPMorgan Healthcare Conference

Date: Wednesday, January 9, 2008

Presentation: 2:30 to 2:55 p.m. Eastern Time (corrected time)

Breakout: 3:00 to 3:25 p.m. Eastern Time (corrected time)

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and older teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit http://www.invisalign.com or call 1-800-INVISIBLE.

Investor Relations Contact Press Contact

Shirley Stacy Shannon Mangum Henderson

Align Technology, Inc. Ethos Communication, Inc.

(408) 470-1150 (678) 540-9222

sstacy@aligntech.com align@ethoscommunication.com


'/>"/>
SOURCE Align Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. iNOS expression may links chronic biliary inflammation to malignant transformation
2. Breast Cancer Genes Also Raise Mens Risk for Malignancy
3. McGill researchers link enzyme to breast cancer malignancy
4. Dallas Among the First to Offer Probiotic Supplement Align(R)
5. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology
6. Threshold Pharmaceuticals Announces Corporate Realignment
7. Test gives insight into prognosis in patients with plasma cell malignancies, finds Mayo Clinic study
8. Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry
9. Align Technology to Announce Third Quarter 2007 Financial Results on October 24, 2007
10. WellPoint Announces Realignment of Core Businesses; Names New Executives
11. Align Technology Executive to Present at Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... 23, 2017 , ... Loyale Healthcare today announced ... Smith joins other recent high-profile hires including Frank Massi, Chief Revenue Officer and ... 1993, helping physician practices and hospitals automate their clinical and financial processes to ...
(Date:8/23/2017)... ... 2017 , ... Earlier this month, the Workgroup for Electronic Data Interchange ... create efficiencies in healthcare information exchange and a trusted advisor to the U.S. Department ... featured keynote addresses by Donald W. Rucker, MD, head of the Office of the ...
(Date:8/23/2017)... ... August 23, 2017 , ... CEFEX, the Centre for Fiduciary ... standards representing best practices in the retirement plan industry. The independent CEFEX Investment ... to verify that NFP’s retirement division focuses on putting clients’ interests first and ...
(Date:8/23/2017)... , ... August 23, 2017 , ... Nightingale College continues ... Give Back Day is a time Nightingale College dedicates to serving and volunteering for ... thrive on donations and volunteers or those that need a little extra help. ...
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... traveling medical professionals, recently launched a new website, http://www.cirrusmedicalstaffing.com . The new ... respond to the needs of healthcare professionals who are traveling on short-term assignments ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
(Date:7/31/2017)... , July 31, 2017 Three Tru-D SmartUVC ... South Korea . Tru-D, short for "Total Room Ultraviolet ... operating rooms after an environmental services (ES) professional cleans the area with ... ... "Although the BAACH ...
(Date:7/28/2017)... Inc. ("Hill-Rom") (NYSE: HRC), today announced financial results for ... updated its financial outlook for fiscal 2017. ... quarter, Hill-Rom reported earnings of $0.09 per diluted share ... period. These results reflect after-tax special items, including a ... the non-cash write-down of assets associated with the planned ...
Breaking Medicine Technology: